Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study
Rutgers, The State University of New Jersey · with National Institute of Mental Health (NIMH) · NCT06745479
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–50 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 74
- US sites recruiting
- 1
- Study start
- January 7, 2025
- Record last updated
- March 11, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to learn if attention and ways of thinking impact decision-making and brain processes related to decision-making in people with schizophrenia or schizoaffective disorder relative to people without either condition. It will also learn how brain functioning during decision-making relates to real-world decisions made during daily life. The main questions it aims to answer are:
- Does paying attention to specific information impact decision-making and brain processes?
- Does thinking in a certain way according to specific 'thinking strategies' improve brain processes related to decision-making?
- Does brain functioning during decision-making relate to real-world choices to engage in activities?
Researchers will compare brain functioning and decision-making on computer tasks of gambling after participants have been trained to use a positive thinking strategy. They will compare what is different in the brain and behavior when participants use this strategy and when they do not. Participants will also answer brief surveys about activities and feelings for a week in their daily lives.
Participants will
- Complete several hours of clinical interviewing, cognitive tests, and surveys of about symptoms, experiences, and personality
- Complete computer tasks about gambling decisions during MRI brain scanning and while having their visual attention measured using eye-tracking
- Complete brief surveys about their activities and feelings 5 times a day for 1 week using a cell phone. Each survey only take several minutes.
Being studied: Positive Emotion Upregulation
Conditions: Schizophrenia; Schizoaffective Disorder; Control Subjects
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
The following criteria apply to all subjects:
- Between ages of 18-50.
- Have capacity to provide informed consent
- Fluent communication in English
- Willingness and ability to follow study requirements, as evidenced by an ability to provide written or virtual informed consent and read, and complete, study procedures.
- Cognitive ability to understand tasks and estimated IQ greater than 70.
The following criteria apply to subjects with schizophrenia:
- Primary diagnosis of schizophrenia or schizoaffective disorder
The following additional criteria apply to subjects without schizophrenia:
- Inclusion based on subject matched to psychiatric group based on age, sex, race/ethnicity, and education level.
Exclusion Criteria
The following criteria apply to all subjects:
- Self-disclosed or noticeable intoxication from alcohol or illicit drugs (e.g., arriving to participate in the study drunk/high)
- Self-disclosure of consistent current substance use other than nicotine, alcohol, or cannabis (e.g. cocaine, heroin).
- Many-year history of severely disordered substance use other than nicotine/tobacco (determined via interview)
- Significant physical health disorder, robust physical health conditions, neurological disease/disorder (e.g., Parkinson's, history of strokes).
- History of traumatic brain injury, head injury resulting in loss of consciousness for an extended duration or with noted neurobehavioral consequences.
- Electroconvulsive therapy within one month of participation.
- History of seizures or epilepsy.
- Currently untreated or unstable psychiatric and medical conditions.
- Intellectual disability
- Contra indications for MR imaging (detailed below)
The following additional criteria apply to subjects without schizophrenia:
- Pervasive history of problematic substance use (other than nicotine, alcohol, and mild-moderate cannabis use) as defined by meeting DSM-5 criteria for a substance use disorder.
- Diagnosis of, or first-degree relative with, significant psychiatric disorder (e.g., bipolar disorder, psychotic disorder, or Cluster A personality disorder).
Recruiting US locations
Center for Advanced Human Brain Imaging Research
Piscataway, NJ 08854
Site contact: Pariya Chanthasensack, BS · 732-235-6438 · CANL@rwjms.rutgers.edu
Study contacts (from the official record)
- Pariya Chanthasensack, BS · 732-235-6438 · CANL@rwjms.rutgers.edu
- John Purcell, PhD · 732-235-6438 · jrp345@rwjms.rutgers.edu
Similar studies in New Jersey
All mental health studies in New Jersey →- RecruitingPhase 1Overnight stay mentioned
A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
Leal Therapeutics, Inc
- Location
- Marlton, NJ + 9 other US sites
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteers
DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer
Ponce Medical School Foundation, Inc.
- Location
- Basking Ridge, NJ + 6 other US sites
- Eligibility basics
- Ages 21–100
- RecruitingHealthy volunteers
Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure
Ecotera Health LLC
- Location
- Newark, NJ + 50 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
Bristol-Myers Squibb
- Location
- Marlton, NJ + 20 other US sites
- Eligibility basics
- Ages 18–65